A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

NCT05726292 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Prostate Adenocarcinoma

Interventions

DRUG: Relacorilant
DRUG: Enzalutamide
OTHER: Placebo (Sugar Pill)
OTHER: Androgen Deprivation Therapy
PROCEDURE: Radical Prostatectomy

Sponsor

University of Chicago